Cargando…

Vaccine hesitancy in the era of COVID-19

OBJECTIVES: In 2019, a new coronavirus has been identified and many efforts have been directed toward the development of effective vaccines. However, the willingness for vaccination is deeply influenced by several factors. So the aim of our review was to analyze the theme of vaccine hesitancy during...

Descripción completa

Detalles Bibliográficos
Autores principales: Troiano, G., Nardi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society for Public Health. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931735/
https://www.ncbi.nlm.nih.gov/pubmed/33965796
http://dx.doi.org/10.1016/j.puhe.2021.02.025
_version_ 1783660351195185152
author Troiano, G.
Nardi, A.
author_facet Troiano, G.
Nardi, A.
author_sort Troiano, G.
collection PubMed
description OBJECTIVES: In 2019, a new coronavirus has been identified and many efforts have been directed toward the development of effective vaccines. However, the willingness for vaccination is deeply influenced by several factors. So the aim of our review was to analyze the theme of vaccine hesitancy during COVID-19 pandemic, with a particular focus on vaccine hesitancy toward COVID-19 vaccine. STUDY DESIGN: Narrative review. METHODS: In November 2020, we performed a search for original peer-reviewed articles in the electronic database PubMed (MEDLINE). The key search terms were “Vaccine hesitancy AND COVID-19”. We searched for studies published during COVID-19 pandemic and reporting information about the phenomenon of vaccine hesitancy. RESULTS: Fifteen studies were included in the review. The percentage of COVID-19 vaccine acceptance was not so high (up to 86.1% students or 77.6% general population); for influenza vaccine, the maximum percentage was 69%. Several factors influenced the acceptance or refusal (ethnicity, working status, religiosity, politics, gender, age, education, income, etc.). The most given reasons to refuse vaccine were as follows: being against vaccines in general, concerns about safety/thinking that a vaccine produced in a rush is too dangerous, considering the vaccine useless because of the harmless nature of COVID-19, general lack of trust, doubts about the efficiency of the vaccine, belief to be already immunized, doubt about the provenience of vaccine. CONCLUSIONS: The high vaccine hesitancy, also during COVID-19 pandemic, represents an important problem, and further efforts should be done to support people and give them correct information about vaccines.
format Online
Article
Text
id pubmed-7931735
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society for Public Health. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79317352021-03-05 Vaccine hesitancy in the era of COVID-19 Troiano, G. Nardi, A. Public Health Review Paper OBJECTIVES: In 2019, a new coronavirus has been identified and many efforts have been directed toward the development of effective vaccines. However, the willingness for vaccination is deeply influenced by several factors. So the aim of our review was to analyze the theme of vaccine hesitancy during COVID-19 pandemic, with a particular focus on vaccine hesitancy toward COVID-19 vaccine. STUDY DESIGN: Narrative review. METHODS: In November 2020, we performed a search for original peer-reviewed articles in the electronic database PubMed (MEDLINE). The key search terms were “Vaccine hesitancy AND COVID-19”. We searched for studies published during COVID-19 pandemic and reporting information about the phenomenon of vaccine hesitancy. RESULTS: Fifteen studies were included in the review. The percentage of COVID-19 vaccine acceptance was not so high (up to 86.1% students or 77.6% general population); for influenza vaccine, the maximum percentage was 69%. Several factors influenced the acceptance or refusal (ethnicity, working status, religiosity, politics, gender, age, education, income, etc.). The most given reasons to refuse vaccine were as follows: being against vaccines in general, concerns about safety/thinking that a vaccine produced in a rush is too dangerous, considering the vaccine useless because of the harmless nature of COVID-19, general lack of trust, doubts about the efficiency of the vaccine, belief to be already immunized, doubt about the provenience of vaccine. CONCLUSIONS: The high vaccine hesitancy, also during COVID-19 pandemic, represents an important problem, and further efforts should be done to support people and give them correct information about vaccines. The Royal Society for Public Health. Published by Elsevier Ltd. 2021-05 2021-03-04 /pmc/articles/PMC7931735/ /pubmed/33965796 http://dx.doi.org/10.1016/j.puhe.2021.02.025 Text en © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Paper
Troiano, G.
Nardi, A.
Vaccine hesitancy in the era of COVID-19
title Vaccine hesitancy in the era of COVID-19
title_full Vaccine hesitancy in the era of COVID-19
title_fullStr Vaccine hesitancy in the era of COVID-19
title_full_unstemmed Vaccine hesitancy in the era of COVID-19
title_short Vaccine hesitancy in the era of COVID-19
title_sort vaccine hesitancy in the era of covid-19
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931735/
https://www.ncbi.nlm.nih.gov/pubmed/33965796
http://dx.doi.org/10.1016/j.puhe.2021.02.025
work_keys_str_mv AT troianog vaccinehesitancyintheeraofcovid19
AT nardia vaccinehesitancyintheeraofcovid19